Delivery Order SPE2DB22D2206-SPE2DB25FFC86

Award Date 1/15/25
Potential Completion Date 2/6/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COMIRNATY 2024-25 (12Y UP) syringes (0.3ML). The contract has a ceiling value of $1,480.58 and a period of performance through February 11, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,293.36, is for the delivery of COMIRNATY 2024-25 (12Y UP) syringes, 0.3 ML. This is a firm fixed price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COMIRNATY 2024-25 (12Y UP) syringes (0.3ML) with a ceiling value of $7,402.80. The contract is a Firm Fixed Price Delivery Order with a completion date of January 7, 2025. The award was made on December 13, 2024, and there was no set-aside designation. AmerisourceBergen holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of COMIRNATY 2024-25 (12 years and up) syringes (0.3 mL). The contract is a Firm Fixed Price Delivery Order with a ceiling value of $10,733.40 and a completion date of December 5, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,232.51, is for the procurement of COMIRNATY 2024-25 (12Y UP) syringes, 0.3 ML, and has an ultimate completion date of January 27, 2025. The contract is a Delivery Order under a Firm Fixed Price structure. No set-aside was used for this award. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,805.60, is for the delivery of COMIRNATY 2024-25 (12Y UP) syringes (0.3 ML) through December 17, 2024. The award is not associated with a set-aside program and appears to be an open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,270.30, is for the delivery of COMIRNATY 2024-25 (12Y UP) syringes, 0.3 ML, with a performance period ending on April 29, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,714.08 and is for the delivery of COMIRNATY 2024-25 (12Y UP) SYRG 0.3ML, which are COVID-19 vaccine syringes. The contract has an ultimate completion date of February 14, 2025 and is a Firm Fixed Price Delivery Order. This award is associated with a larger Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,961.16 firm fixed price delivery order is for COMIRNATY 2024-25 (12Y UP) syringes, 0.3ML, with a completion date of February 4, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a $2,220.84 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of COMIRNATY 2024-25 (12Y UP) syringes at 0.3 ML, with a completion date of December 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a wide range of pharmaceutical products and...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFC86
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COMIRNATY 2024-25 (12Y UP) syringes 0.3 ML, with a ceiling value of $1,480.58. It is a firm fixed-price delivery order contract that does not have a set-aside designation, indicating open competition.

The contract is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

Generated 4/17/25, 8:58 AM